CAH
63
3
BRK.B
33
-14
APH
56
7
EFX
54
2
D
41
-4
APA
53
5
CA
30
3
BF.B
48
-2
CRM
70
18
CCI
36
2
AMG
77
3
AON
62
-5
AKAM
64
2
EOG
33
-3
BA
47
4
AIG
77
2
BEN
55
2
CMS
60
-2
CNX
49
3
AIZ
78
2
CAH
63
3
BRK.B
33
-14
APH
56
7
EFX
54
2
D
41
-4
APA
53
5
CA
30
3
BF.B
48
-2
CRM
70
18
CCI
36
2
AMG
77
3
AON
62
-5
AKAM
64
2
EOG
33
-3
BA
47
4
AIG
77
2
BEN
55
2
CMS
60
-2
CNX
49
3
AIZ
78
2
Financhill
Back

Neurocrine Biosciences, Inc. Stock Predictions

Valuation Up 5,000%. Shares Now $0.85 - Still Early?

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
58

NBIX
Neurocrine Biosciences, Inc.

Last Price:
$144.97
Seasonality Move:
8.49%

7 Day Trial

ALL ACCESS PASS

$ 7

14K Investors Got In Earlier. You Still Can.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Neurocrine Biosciences, Inc. Stock Forecast

  • Over the next 52 weeks, Neurocrine Biosciences, Inc. has on average historically risen by 28.5% based on the past 29 years of stock performance.
  • Neurocrine Biosciences, Inc. has risen higher in 16 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.17%
  • Is Neurocrine Biosciences, Inc. Stock Undervalued?
    The current Neurocrine Biosciences, Inc. [NBIX] share price is $145.00. The Score for NBIX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • NBIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Neurocrine Biosciences, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Neurocrine Biosciences, Inc. has on average historically risen by 28.5% based on the past 29 years of stock performance.

Neurocrine Biosciences, Inc. Stock Rating

Buy
58
Neurocrine Biosciences, Inc. (NBIX) is a Buy

Is Neurocrine Biosciences, Inc. overpriced?

  • Neurocrine Biosciences, Inc. has risen higher in 16 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.17%

Neurocrine Biosciences, Inc. Stock Price History

Is NBIX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurocrine.com

52-Week Data

52-Week High:
160.18
52-Week Low:
84.23

Prediction Charts

Market Cap:
14.5B
Price in USD:
145.00
Volume:
2M
Beta:
0.78

Technical Analysis

SMA50:
145.87
SMA100:
141.53
SMA200:
129.69
52-Wk Change:
7.44%

Stock Predictions

  • Is Neurocrine Biosciences, Inc. stock public?
    Yes, Neurocrine Biosciences, Inc. is a publicly traded company.
  • What is the Neurocrine Biosciences, Inc. stock quote today?
    The Neurocrine Biosciences, Inc. stock price is 145.00 USD today.
  • How to buy Neurocrine Biosciences, Inc. stock online?
    You can buy Neurocrine Biosciences, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-2 151.13 152.48 153.79 150.84
Dec-3 153.20 151.96 154.35 150.26
Dec-4 152.00 154.22 154.31 151.01
Dec-5 154.47 155.51 156.76 153.38
Dec-8 156.65 154.99 160.18 154.74
Dec-9 153.45 155.02 156.27 152.29
Dec-10 155.87 155.63 156.70 151.59
Dec-11 153.39 154.75 156.46 153.30
Dec-12 155.00 152.80 155.29 151.09
Dec-15 152.78 154.06 155.55 151.12
Dec-16 155.23 148.74 155.23 148.03
Dec-17 150.47 141.70 150.47 141.61
Dec-18 141.78 141.84 144.23 141.23
Dec-19 142.97 145.00 145.95 141.00

Neurocrine Biosciences, Inc. Earnings

Neurocrine Biosciences, Inc. Earnings Report: Per Share Neurocrine Biosciences, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Neurocrine Biosciences, Inc. Forecast Revenue Growth

Neurocrine Biosciences, Inc. Stock Analysis: Historical quarterly revenues per share for Neurocrine Biosciences, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $2.30 per share.

* Neurocrine Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.